Synopsys delivered its earnings after the bell on August 26, and the immediate market reaction has shifted the week's story: the stock jumped 3.6% on Tuesday to $408.79, short sellers cut positions sharply, and the gap between where the stock trades and where analysts think it belongs narrowed — though it remains wide.
The most concrete development is on the short side, and it accelerates a trend already in place. Short interest dropped 16% over the past week to 2.36% of the float — roughly 4.4 million shares — its lowest level in the 30-day lookback window. The prior two weekly notes flagged bears stepping back ahead of the print; Tuesday's data shows that retreat continued through and past the release. Borrow conditions reinforce the picture: cost to borrow is just 0.39%, and availability is effectively uncapped — the lending pool holds nearly 190 million shares against fewer than 4.4 million borrowed, leaving no squeeze dynamic in play. The ORTEX short score has ticked down to 31.4, its lowest reading in the history shown, confirming that the short-side pressure on this name is at a multi-month low.
Options tell a quieter story, and that's notable given the occasion. The put/call ratio of 1.21 is almost exactly in line with its 20-day average of 1.21 — a z-score of essentially zero — meaning options traders neither rushed for downside protection ahead of the print nor scrambled to chase upside after it. The range is wide over the past year (52-week low 0.43, high 1.35), which makes the current flat reading all the more striking: neither camp pressed its view through the derivatives market.
The Street debate has not resolved cleanly despite the move. The consensus mean target of $560 still implies roughly 37% upside from Tuesday's close, a gap that remains wide by any standard. The bull case — dominant EDA platform, AI-driven design complexity driving tool demand, analyst targets from Rosenblatt, Citigroup, and Stifel clustered between $575 and $610 — argues the market is simply undervaluing a structural winner. The bear case is more textured: Morgan Stanley trimmed its target to $500 from $525 just last week, Wells Fargo cut to $450 from $535 the week before, and the EPS surprise factor score ranks in the 20th percentile, meaning Synopsys has not been beating estimates convincingly. May's quarterly print dropped the stock 10% in a single session; this week's initial 3.6% bounce is a different character, but the trend of target cuts from neutral-rated houses hasn't reversed yet.
The last earnings reaction is still relevant context. May's print produced a 10% one-day decline and a further 7% over five days — the kind of outcome that can make institutional holders cautious about adding aggressively into any single-session relief rally. That history sits alongside a valuation profile that has re-rated: the price-to-earnings multiple has expanded about 8% over the past 30 days, now near 25.8x trailing, while EV/EBITDA has compressed slightly. Neither extreme, but both consistent with a stock beginning to recover from its 2026 underperformance.
Closest peer CDNS — the EDA market's other anchor — gained 5.1% on the day and 4.9% on the week, running slightly ahead of Synopsys across both windows, which suggests sector tailwinds rather than a name-specific rerating. How management characterises the forward EDA demand environment and any update on AI-assisted design adoption will determine whether this week's short covering becomes a broader institutional re-engagement or simply reflects bears taking profits after a crowded setup into the print.
See the live data behind this article on ORTEX.
Open SNPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
